CD274 and non-small cell lung carcinoma: Alternative treatment with immune checkpoints inhibitors provided promising response rates and prolonged PFS and OS in NSCLC as monotherapy in patients with high PD‐L1 expression and in combination with chemotherapy independent of PD‐L1 status.23, 24, 25